Resources from the same session
Welcome & Introducion
Presenter: Martin Wermke
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast
Emerging targeted therapies in lung cancers of neuroendocrine origin: DLL3
Presenter: Martin Wermke
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast
Selectively targeting HER2 in NSCLC
Presenter: Jon Zugazagoitia
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast
Panel discussion and audience Q&A
Presenter: Martin Wermke, Gerrina Ruiter, Jon Zugazagoitia
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast